Unitaid

Partners announce reduced price for patient-friendly TB preventive treatments

Partners announce two new agreements to lower the price of rifapentine-based treatments to prevent TB in low- and middle-income countries.

Read More →

#RightToPreventTB campaign: TB preventive treatment is a human right!

The #RightToPreventTB campaign focuses attention on the urgent need to scale-up TB preventive treatment as a matter of human rights.

Read More →

Digital technologies support patients with treatment from a distance, allowing more flexibility in care

As the Unitaid-funded ASCENT project launches the main research phase, investigating the effectiveness of digital adherence technologies and data-driven support interventions on TB treatment completion and success rates, Unitaid asked the researchers leading the study to tell more about their work and its potential impact.

Read More →

Research begins into new digital tools to support patients and healthcare workers through TB treatment

The Hague / Geneva, 4 August 2021 – A large global study which aims to determine if digital adherence technologies (DATs) can provide more patient-friendly approaches to improve tuberculosis (TB) treatment outcomes launches in Ethiopia, Tanzania, South Africa, the Philippines and Ukraine, as part of the ASCENT project.

Read More →

Unitaid invests in long-acting medicines to simplify treatment and prevention for HIV, TB, malaria and HCV

Geneva, 30 January 2020 – Unitaid will invest US$ 39 million in two projects to speed up the development of long-acting versions of medicines for low- and middle-income countries. Innovative ways to administer drugs, which have revolutionized contraception and the treatment of schizophrenia, could redefine prevention and treatment of infectious diseases, but remain at early stages of research because of market barriers.

Read More →

Unitaid introduces its newest TB-fighting projects at Union World Conference

Hyderabad, India – Unitaid and partners launched a trio of innovations today (November 1) that will work together to fight tuberculosis through gene-based diagnosis, better treatments and ingenious technologies that help patients remember to take their medicines.

Read More →

Unitaid invests in groundbreaking technologies to help patients succeed in TB treatment

Geneva, 23 July 2019 – The KNCV Tuberculosis Foundation and Unitaid signed a US$ 13.9 million grant agreement on Tuesday to increase the use of smart pillboxes and mobile technology, aiming to help patients adhere to their medicines and raise the world’s plateauing cure rates for TB.

Read More →

Unitaid’s investment in TB hits record levels with new grant for diagnostic technologies

Geneva – The Foundation for Innovative New Diagnostics (FIND) and Unitaid signed a US$ 14.5 million grant Thursday (July 4) to deploy a powerful new technology in the diagnosis of drug-resistant tuberculosis.

Read More →

UNICEF and Unitaid join forces to improve the health of children, adolescents and mothers

Geneva, 29 May 2019 –Unitaid and UNICEF will collaborate to save the lives of more children, adolescents and mothers, an agreement formalized by a memorandum of understanding signed today.

Read More →

Unitaid and Japan move to align their efforts against TB

Tokyo, 2 April 2019 — Unitaid Executive Director Lelio Marmora and Parliamentary Vice-Minister for Foreign Affairs of Japan Kenji Yamada met today to discuss a new alignment between Japan’s global health priorities and Unitaid’s work in fighting tuberculosis.

Read More →

Page 1 of 3 · Total posts: 10

1 2 Last→